SOLENYX
Sign In / Register
Therapeutic Innovation

Precision therapeutics.
Clinically validated.

Our pharmaceutical division develops high-efficacy, targeted delivery systems for chronic pain, metabolic disorders, and musculoskeletal health.

90%
Pain relief in 5 min
80%
Joint mobility gain
GMP
Manufacturing certified
View Pipeline Partner With Us
Research Focus

Addressing the most prevalent health challenges.

Musculoskeletal Pain

Topical roll-on formulations targeting joints, bones, and connective tissue for fast localized relief.

80%
Mobility improvement in 1 week

Metabolic Health

Dual-action compounds targeting insulin sensitivity and weight management through metabolic pathway modulation.

10-20%
Weight reduction improving outcomes

Topical Delivery Systems

Proprietary penetration-enhancing technologies that deliver actives directly to the target tissue.

5 min
Onset of action for roll-on products
Development Pipeline

From research bench to patient care.

Advanced topical and oral therapeutics designed to address musculoskeletal and metabolic health challenges.

Topical Roll-OnClinical Phase II

Solenyx™ Advanced Joint & Bone Relief

A GMP-grade, topical roll-on formulation designed to provide immediate, localized relief using clinically supported, natural and semi-synthetic ingredients. Delivers rapid penetration to affected muscles, joints, and bones.

Clinical Highlight

70–80% reduction in joint pain within 6 minutes.

View Specifications
Tablet / CapsuleClinical Phase II

Solenyx™ Diabetzall®

A scientifically formulated solution designed to support healthy blood glucose levels while promoting sustainable weight management. Targets key metabolic pathways to improve insulin sensitivity and reduce systemic inflammation.

Clinical Highlight

Improves glycemic control (fasting and post-prandial).

View Specifications
Chemical Infrastructure

Architecting
Efficacy.

GMP-certified compounding and advanced pharmacokinetic modulation across localized and systemic metabolic pathways.

Modality .01

Transdermal Permeation

Our proprietary lipid nanoparticle vehicles allow large-molecule active ingredients to bypass the stratum corneum with 8x greater efficiency than standard topical roll-ons.

Explore Permeation Data
Modality .02

Receptor Targeting

Selective agonism designed to lock onto localized pain receptors without crossing the blood-brain barrier.

Modality .03

Metabolic Synergism

Orally bioavailable compounds that amplify baseline insulin sensitivity rather than forcing artificial secretion.

Clinical Archive

View Phase II Results

Proprietary Platform

Specialized delivery systems.

Our pharmaceutical focus is on novel delivery mechanisms that optimize therapeutic indices and reduce systemic side effects — improving both clinical outcomes and patient compliance.

01

Topical Optimization

Enhanced penetration for localized joint and bone relief without systemic exposure.

02

Metabolic Targeting

Small molecule research for insulin sensitivity and weight modulation.

03

AI-Accelerated Discovery

Machine learning identifies novel compounds and formulation pathways.

Building the infrastructure of tomorrow's medicine.

Whether you are a researcher, clinician, or partner, let's accelerate the path to better health outcomes together.